Paroxetine in the treatment of post-traumatic stress disorder: Pooled analysis of placebo-controlled studies

Expert Opinion on Pharmacotherapy

Volumn 4, Issue 10, 2003, Pages 1829-1838

  Stein, Dan J ^a,d   Davidson, Jonathan ^b   Seedat, Soraya ^a,d   Beebe, Katherine ^c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Anxiety disorders; Paroxetine; Pharmatherapy; Post traumatic stress disorder; Selective serotonin re uptake inhibitors

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; LAMOTRIGINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISABILITY; DISEASE ASSOCIATION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DRUG SELECTIVITY; DRUG TOLERABILITY; DRUG USE; FEMALE; HEADACHE; HUMAN; INTERMETHOD COMPARISON; MAJOR DEPRESSION; MALE; METHODOLOGY; NAUSEA; POSTMARKETING SURVEILLANCE; POSTTRAUMATIC STRESS DISORDER; PSYCHOTHERAPY; REMISSION; SEX DIFFERENCE; SLEEP DISORDER; SOMNOLENCE; SYMPTOM; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; HUMANS; PAROXETINE; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 0142210224     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.4.10.1829     Document Type: Article

References (36)

1. AMERICAN PSYCHIATRIC ASSOCIATION: Diagnostic and Statistical Manual of Mental Disorders (4th edn) (1994).
2. SHAY J: Archilles in Vietnam: combat trauma and the undoing of character. Touchstone Books (1995).
3. YEHUDA R, MCFARLANE AC: Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis. Am. J. Psychiatry (1995) 152:1705-1713.
4. CHARNEY DS, DEUTCH AY, KRYSTAL JH, SOUTHWICK SM, DAVIS M: Psychobiologic mechanisms of posttraumatic stress disorder. Arch. Gen. Psychiatry (1993) 50:295-305.
5. CONNOR KM, DAVIDSON JRT: The role of serotonin in posttraumatic stress disorder: neurobiology and pharmacotherapy. CNS Spectr. (1998) 3(2):43-51.
6. KESSLER RC, SONNEGA A, BROMET E et al.: Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psych. (1995) 52:1048-1060.
7. GREENBERG PE, SISITSKY T, KESSLER RC et al.: The economic burden of the anxiety disorders in the 1990s. J. Clin. Psychiatry (1999) 60:427-435.
8. KESSLER RC: Posttraumatic stress disorder: the burden to the individual and to society. J. Clin. Psychiatry (2002) 61(Suppl. 5):4-12.
9. BALLENGER JC, DAVIDSON JR, LECRUBIER Y et al.: Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. J. Clin. Psychiatry (2000) 61(Suppl. 5):60-66.
10. STEIN DJ, ZUNGU-DIRWAYI N, VAN DER LINDEN GJ, SEEDAT S: Pharmacotherapy for posttraumatic stress disorder. Cochrane Database of Systematic Reviews (2000) 4:CD002795.
11. FOA EB, DAVIDSON JRT, FRANCES A: Treatment of posttraumatic stress disorder: the expert consensus guideline series. J. Clin. Psychiatry (1999) 60:1-76.
12. FOA EB, KEANE TM, FRIEDMAN MJ: Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies (2000).
13. BANDELOW B, ZOHAR J, HOLLANDER E et al.: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. WFSBP Task Force On Treatment Guidelines For Anxiety Obsessive-compulsive And Posttraumatic Stress Disorders: World J. Biol. Psychiatry (2002) 3:171-199.
14. AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J. Am. Acad. Child Adolesc. Psychiatry (1998) 37S:4-26.
15. CONNOR KM, DAVIDSON JRT: The role of serotonin in posttraumatic stress disorder: neurobiology and pharmacotherapy. CNS Spectr. (1998) 3(2):43-51.
16. SOUTHWICK SM, KRYSTAL JH, BREMNER JD et al.: Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch. Gen. Psychiatry (1997) 54:749-758.
17. PENAVA SJ, OTTO MW, POLLACK MH, ROSENBAUM JF: Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies. Depress. Anx. (1996) 4:240-242.
18. DOW B, KLINE N: Antidepressant treatment of posttraumatic stress disorder and major depression in veterans. Ann. Clin. Psychiatry (1997) 9:1-5.
19. VAN DER KOLK BA, DREYFUSS D, MICHAELS M et al.: Fluoxetine in posttraumatic stress disorder. J. Clin. Psychiatry (1994) 55:517-522.
20. STEIN DJ, SEEDAT S, VAN DER LINDEN GJ, ZUNGU-DIRWAYI N: Selective serotonin reuptake inhibitors in the treatment of post-traumatic stress disorder: a meta-analysis of randomized controlled trials. Int. Clin. Psychopharmacol. (2000) 15(Suppl. 2):S31-S39.
21. DAVIDSON JR, WEISLER RH, BUTTERFIELD MI et al.: Mirtazapine versus placebo in posttraumatic stress disorder: a pilot trial. Biol. Psychiatry (2003) 53:188-191.
22. HAMNER MB, FALDOWSKI RA, ULMER HG, FRUEH BC, HUBER MG, ARANA GW: Adjunctive risperidone treatment in post-traumatic stress disorder: A preliminary controlled trial of effects on comorbid psychotic symptoms. Int. Clin. Psychopharmacol. (2003) 18:1-8.
23. STEIN MB, KLINE NA, MATLOFF JA: Ajdunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am. J. Psychiatry (2003) 159:1777-1779.
24. HERESCO-LEVY U, KREMER I, JAVITT DC et al.: Pilot-controlled trial of D-cycloserine for the treatment of posttraumatic stress disorder. Int. Clin. Neuropsychopharmacol. (2002) 5:301-307.
25. PITMAN RK, SANDERS KM, ZUSMAN RM et al.: Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol. Psychiatry (2002) 51:189-192.
26. WAGSTAFF AJ, CHEER SM, MATHESON AJ, ORMROD D, GOA KL: Paroxetine: an update of its use in psychiatric disorders in adults. Drugs (2002) 62:655-703.
27. MARSHALL RD, SCHNEIER FR, KNIGHT CBG et al.: An open trial of paroxetine in patients with non-combat-related chronic PTSD. J. Clin. Psychopharmacol. (1998) 18:10-18.
28. MARSHALL RD, BEEBE KL, OLDHAM M, ZANINELLI R: Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am. J. Psychiatry (2001) 158:1982-1988.
29. TUCKER P, ZANINELLI R, YEHUDA R, RUGGIERO L, DILLINGHAM K, PITTS CD: Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J. Clin. Psychiatry (2001) 62:860-868.
30. STEIN DJ, DAVIDSON JRT, HEWETT K: Paroxetine in the pharmacotherapy of post-traumatic stress disorder. Presented at the Biannual Congress of the Collegium Internationale Neuropsychopharmacologicum (2000).
31. DAVIDSON JRT, HEWETT K, BRYSON HEA: Post-traumatic stress disorder: remission rates following paroxetine treatment. Presented at the Biannual Congress of the Collegium Internationale Neuropsychopharmacologicum, Montreal (2002).
32. SHEEHAN D, BEEBE KL, DUBE EM: Paroxetine for the treatment of sleep disturbance in posttraumatic stress disorder. Presented at the Biannual Congress of the Collegium Internationale Neuropsychopharmacologicum, Montreal (2002).
33. FRIEDMAN MJ, DUBE EM, BEEBE KL et al.: Paroxetine effectively treats posttraumatic stress disorder (PTSD) in males. Presented at the Biannual Congress of the Collegium Internationale Neuropsychopharmacologicum, Montreal (2002).
34. KORNSTEIN SG, SCHATZBERG AF, THASE ME et al.: Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am. J. Psychiatry (2000) 157:1445-1452.
35. FROMMBERGER U, NYBERG E, RICHTER H, STIEGLITZ R-D, BERGER M: Paroxetine versus cognitive-behavioral therapy in the treatment of depression in PTSD patients. Presented at the 21st Collegium Internationale Neuropsychopharmacologicum, Glasgow, July (1998).
36. BRADY K, PEARLSTEIN T, ASNIS GM et al.: Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA (2000) 283:1837-1844.